Skip to main content

Notice

We are in the process of rolling out a soft launch of the RDA website, which includes a new member platform. Existing RDA members PLEASE REACTIVATE YOUR ACCOUNT using this link: https://rda-login.wicketcloud.com/users/confirmation. Visitors may encounter functionality issues with group pages, navigation, missing content, broken links, etc. As you explore the new site, please provide your feedback using the UserSnap tool on the bottom right corner of each page. Thank you for your understanding and support as we work through all issues as quickly as possible. Stay updated about upcoming features and functionalities: https://www.rd-alliance.org/rda-web-platform-upcoming-features-and-functionalities/

health data and irb’s

  • Creator
    Discussion
  • #71326

    Hi all,
    I have recently identified an area which might be of more urgent need
    the research datasets. Currently our institution is trying to obtain
    something called IRB (Institutional Review Board) approval for COVID19
    research data. Each institution who conducts medial research in the USA
    needs an IRB to conduct research but some IRB’s are move more quickly
    then others.   An IRB’s goal is to protect patients privacy and rights
    and providing a method to review ethical use a study.   Applying to a
    IRB is typically a timely endeavor and is often a back and forth between
    a researcher and the IRB until a protocol for a study is established.  
    The interesting thing about IRB’s is one institutional IRB can be used
    by other institutions if they are part of the study.   It I believe a
    clearing house for IRB established studies would be greatly help the
    community.
    Additionally, a method for review of computational infrastructure and
    security practices, and by proxy a chain of trust to who is responsible
    for data security at a given institution would also be very helpful.  
    Knowing who  is able to secure and process sensitive data is very
    useful.   For example, I know the department of Biostatistics and
    Medical Informatics at the University of Wisconsin – Madison is a
    Medically covered entity and can run analysis of HIPAA protected data.  
    I also happen to run the 2800CPU core cluster for this department.   So
    having a collaborator within this department would likely be helpful, I
    know other departments like ours exist so having a list of people to
    collaborate with would likely also be of use.
    Having worked in this field, I know it takes time to obtain
    de-identified data for use by the general public.   I have worked with
    researchers who have taken 2+ years obtaining data (IRB + honest broker
    de-identify steps), which is part of the reason medical research is so
    slow.
    Thoughts,
        -C

    Christopher Harrison
    Systems Engineer
    Department of Biostatistics & Medical Informatics
    University of Wisconsin School of Medicine and Public Health
    J4/503 CSC, Box 4675
    600 Highland Avenue
    Madison, WI 53792-4675
    608.3476.6967

Page 2 of 2
  • Author
    Replies
  • #90917

    RDA Admin
    Organizer

    Hi All,
    Indeed, there are existing biomedical repositories that already include COVID19 datasets. Take a look at http://datamed.org , which indexes 2.3+ mln biomedical datasets. They already add “Covid-19” tags to relevant datasets (eg https://datamed.org/search.php?query=covid&searchtype=data) . Perhaps RDA can work with DataMed on this. I cc to Lucila Ohno-Machado from UCSD and Hua Xu from UT-Health who can give you more info.
    Best regards,
    – Ilya
    __________________________________
    Ilya Zaslavsky, Ph.D.
    Director, Spatial Information Systems Lab
    San Diego Supercomputer Center
    University of California San Diego
    9500 Gilman Drive, MC-0505
    La Jolla, CA 92093-0505
    858.534.8342 (ph)
    ***@***.***
    – Show quoted text -From: ***@***.***-groups.org
    Sent: Thursday, April 2, 2020 11:21 PM
    To: ***@***.***; RDA-COVID19
    Subject: Re: [rda-covid19] health data and irb’s
    Hi all,
    Adding my voice and thoughts to the mix here.
    I agree with the overall sentiment here that this should not be about setting up a repository. I’m also not convinced that the role of RDA and this WG is to establish a metadata repository… though I think this would be hugely valuable, I’m not sure RDA is set up in a way that can create, and maintain such a capability. I think it maybe better to look for existing metadata repository providers and looking to them to expand/re-purpose their capability to provide such a service.
    In regards to the purpose of this group and how we can add value here, I’d like to draw attention to what is different in the current situation to what RDA does normally. (and forgive me if I’m stating something that is obvious or have already been recoginsed).
    * Normal work we do in RDA is around trying to codify the complicate data landscape so that we have convergence of thoughts, ideas, and practices leading to best-practices etc.
    * Right now, we are in chaos! The world has been thrown into chaos and what this group is doing is to help everyone make sense of what is going on, and provide some framework for this to occur in, at the fastest possible pace.
    I think the Cynefin framework provides some good guidance on how to approach the current situation, and our task at hand. Normally RDA work is primarily around taking what is in the Complicated domain, and making it Simple. Currently we are very much squarely in the Chaotic state when it comes to how to respond to COVID-19. Right now, our role here is to help the world move from the Chaotic domain to the Complex domain as quickly as possible.
    [image.png]
    Why I think this is important here is because it can change HOW we go about doing the work here. While we typically deliberate long and hard at RDA on picking the Best practice/framework from all that is available, what is required now is to pick/develop some framework quickly, and put it out there for guidance and use. We should then look at how that has helped, and continually iterate over this looking at emergent uses.
    Also, as RDA members, we have an extensive network for disseminating information. Looking at the discussions and comments that are flowing through in the group mail, there are many valuable ideas, initiatives going on. One thing we could do is find a ways of looking at is going on across the world that are worthy of adoption/adaption by others, and disseminating that through our networks for others to build upon.
    Another area that I would like to draw attention to is the work by Dave Jones at ESIP on Operational Readiness Levels for data(Slide deck, webinar recording). This provides a framework for rapidly evaluating the ‘usable’ value of data in a fast changing environment. Establishing something akin to this would allow classification of the growing volume of data, into there fitness for use/reuse.
    [image.png]
    Kind regards
    Kheeran
    On Fri, Apr 3, 2020 at 10:03 AM kristan.kang via RDA-COVID19 wrote:
    I strongly agree with the sentiment of Simon’s comment, and Sarah’s reminder that the aim of the WG is to establish guidelines, not infrastructure.
    To those in the WG frustrated by the delays that buracracy cause in sharing and accessing data – I understand this as I dealt with it for over a decade, so I support making the buracratic process as efficient as possible. However this should not be at the stake of the moral and legal principles that underpin the IRB/ethics-review process and researchers should not take it onto themselves to temporarily suspend the legal and ethical requirement to respect individuals’ right to privacy as they see fit. This would not only be damaging for health research everywhere, but would also put those researchers on dangerous footing with their employers and the law.

    Full post: https://www.rd-alliance.org/group/rda-covid19/post/health-data-and-irbs
    Manage my subscriptions: https://www.rd-alliance.org/mailinglist
    Stop emails for this post: https://www.rd-alliance.org/mailinglist/unsubscribe/68906

  • #90916

    Hello members of this working group,

    Clearly, ethics and especially IRBs are an important area and the competence to address this domain is present in the working group.

    We have in the working group people specialised in ethics and in law ; there will obviously be guidelines in this domain in what will be produced.

    We are organising the discussions in the group and sub-groups so that areas of importance are all considered in a structured way. Prepare your points of discussions; they are precious. But please wait to get the process and tools to share them. Can we ask to refrain from sending personal examples to the whole e-mail list at the moment.

    This will be treated. There already are examples of legal acceleration of procedures without renouncing to protect rights of people and there are legal measures or specific recommendations well framed as this question did not appear only a few weeks ago. Solutions to such questions dealing with fundamental rights are not based on individual solutions. The international bioethics committee of UNESCO has also for example a recent declaration in the context of COVID-19 as well as the European Group for Ethics in Science and new Technologies. The legal solutions and relevant recommendations and authorised practices are also data to be shared and they will be.

    Thanks all for taking part in the working group and let’s be organised to be efficient! Tools and moderators to organise the discussions are being put in place, but it was important to re-assure the group that this will be properly considered.

    For the Chairs of this RDA-working group

    Anne Cambon-Thomsen, co-Chair of the RDA COVID-19 WG, Ambassador of RDA Europe for health sciences and research ethics, Member of the European Group on Ethics of Science and New Technologies

  • #90915

    RDA Admin
    Organizer

    > Christopher
    > Thanks for the interest
    > I guess it depends where you are coming from
    > Medical research is highly regulated and institutionalised with strong
    > influence of large pharmaceuticals
    > as we know- what I do is save a life if I can – often mine – in situations
    > where there is no other option than take a risk of experimental approaches
    > Maybe this community is made up of geeks or medical professionals, I am a
    > field worker
    > and do what I have to
    > I have updated the protocol BTW – look forward to be discussing offlist
    > how to possibly
    > collaborate
    >
    > https://www.protocols.io/view/emergency-medicine-em-protocol-for-the-all
    >
    > Thanks for interst
    > PDM
    >
    > On Thu, Apr 2, 2020 at 9:22 PM Christopher D. Harrison ***@***.***> wrote:
    >
    >> Dr Paola Di Maio,
    >> Thanks for the information and understanding of this situation.
    >> Unfortunately I really do not think the rest of the RDA community
    >> understands all the restrictions and red tape involved in medical research,
    >> sigh. I am going to ask my community for interested in joining you in a
    >> collaboration. I do have collaborators with lab facilities and I will
    >> get back to you soon with interested parties.
    >>
    >> -C
    >>
    >>
    >>
    >>
    >> On 4/2/20 12:55 AM, ***@***.*** wrote:
    >>
    >> Harrison
    >>
    >> Thanks for sharing your concerns
    >>
    >> I am also a systems engineer doubling as anything that is needed,
    >> now in clinical emergency
    >>
    >> I am temporarily bypassing restrictions publishing protocols and
    >> hopefully soon some results here
    >> https://protocols.io/share/DfVgOaP
    >>
    >> Here is one of my protocols for EM treatment of covid
    >>
    >> https://www.protocols.io/view/emergency-medicine-em-protocol-for-the-all
    >>
    >>
    >> I am looking for trial partners with Lab facilities for a clinical study
    >>
    >> Let me know if you or others are interested in a collaboration
    >>
    >> Dr Paola Di Maio
    >>
    >>
    >>
    >>
    >> On Thu, Apr 2, 2020 at 9:01 AM harrison via RDA-COVID19 > ***@***.***-groups.org> wrote:
    >>
    >>> Hi all,
    >>>
    >>> I have recently identified an area which might be of more urgent need
    >>> the research datasets. Currently our institution is trying to obtain
    >>> something called IRB (Institutional Review Board) approval for COVID19
    >>> research data. Each institution who conducts medial research in the USA
    >>> needs an IRB to conduct research but some IRB’s are move more quickly
    >>> then others. An IRB’s goal is to protect patients privacy and rights
    >>> and providing a method to review ethical use a study. Applying to a
    >>> IRB is typically a timely endeavor and is often a back and forth between
    >>> a researcher and the IRB until a protocol for a study is established.
    >>> The interesting thing about IRB’s is one institutional IRB can be used
    >>> by other institutions if they are part of the study. It I believe a
    >>> clearing house for IRB established studies would be greatly help the
    >>> community.
    >>>
    >>> Additionally, a method for review of computational infrastructure and
    >>> security practices, and by proxy a chain of trust to who is responsible
    >>> for data security at a given institution would also be very helpful.
    >>> Knowing who is able to secure and process sensitive data is very
    >>> useful. For example, I know the department of Biostatistics and
    >>> Medical Informatics at the University of Wisconsin – Madison is a
    >>> Medically covered entity and can run analysis of HIPAA protected data.
    >>> I also happen to run the 2800CPU core cluster for this department. So
    >>> having a collaborator within this department would likely be helpful, I
    >>> know other departments like ours exist so having a list of people to
    >>> collaborate with would likely also be of use.
    >>>
    >>> Having worked in this field, I know it takes time to obtain
    >>> de-identified data for use by the general public. I have worked with
    >>> researchers who have taken 2+ years obtaining data (IRB + honest broker
    >>> de-identify steps), which is part of the reason medical research is so
    >>> slow.
    >>>
    >>>
    >>> Thoughts,
    >>> -C
    >>>
    >>>
    >>> —
    >>> Christopher Harrison
    >>> Systems Engineer
    >>> Department of Biostatistics & Medical Informatics
    >>> University of Wisconsin School of Medicine and Public Health
    >>> J4/503 CSC, Box 4675
    >>> 600 Highland Avenue
    >>> Madison, WI 53792-4675
    >>> 608.3476.6967
    >>>
    >>>
    >>> —
    >>> Full post:
    >>> https://www.rd-alliance.org/group/rda-covid19/post/health-data-and-irbs
    >>> Manage my subscriptions: https://www.rd-alliance.org/mailinglist
    >>> Stop emails for this post:
    >>> https://www.rd-alliance.org/mailinglist/unsubscribe/68906
    >>>
    >>>
    >> —
    >> Christopher Harrison
    >> Systems Engineer
    >> Department of Biostatistics & Medical Informatics
    >> University of Wisconsin School of Medicine and Public Health
    >> J4/503 CSC, Box 4675
    >> 600 Highland Avenue
    >> Madison, WI 53792-4675
    >> 608.3476.6967
    >>
    >>

Page 2 of 2

Log in to reply.